Evidence map›Paper›PMID 40218239›Full record

ReviewDiagnostics (Basel, Switzerland)2025

Role of Artificial Intelligence in the Diagnosis and Management of Pulmonary Embolism: A Comprehensive Review.

Ahmad Moayad Naser, Rhea Vyas, Ahmed Ashraf Morgan, Abdul Mukhtadir Kalaiger, Amrin Kharawala, Sanjana Nagraj, Raksheeth Agarwal, Maisha Maliha, Shaunak Mangeshkar, Nikita Singh and 4 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ahmad Moayad NaserDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.
Rhea VyasDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.
Ahmed Ashraf MorganDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.
Abdul Mukhtadir KalaigerDepartment of Medicine, Montefiore Wakefield Medical Center, New York, NY 10461, USA.
Amrin KharawalaDepartment of Cardiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0003-3989-4489
Sanjana NagrajDepartment of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY 10461, USA.ORCID 0000-0002-6230-7214
Raksheeth AgarwalDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.ORCID 0000-0003-4045-2784
Maisha MalihaDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.
Shaunak MangeshkarDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.
Nikita SinghDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.ORCID 0000-0003-0132-3285
Vikyath SatishDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.ORCID 0000-0003-4954-2620
Sheetal MathaiDepartment of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY 10461, USA.ORCID 0000-0002-3254-4841
Leonidas PalaiodimosDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.ORCID 0000-0003-4682-5991
Robert T FaillaceDepartment of Medicine, New York City Health + Hospitals/Jacobi, Albert Einstein College of Medicine, New York, NY 10461, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary embolism (PE) remains a critical condition with significant mortality and morbidity, necessitating timely detection and intervention to improve patient outcomes. This review examines the evolving role of artificial intelligence (AI) in PE management. Two primary AI-driven models that are currently being explored are deep convolutional neural networks (DCNNs) for enhanced image-based detection and natural language processing (NLP) for improved risk stratification using electronic health records. A major advancement in this field was the FDA approval of the Aidoc© AI model, which has demonstrated high specificity and negative predictive value in PE diagnosis from imaging scans. Additionally, AI is being explored for optimizing anticoagulation strategies and predicting PE recurrence risk. While further large-scale studies are needed to fully establish AI's role in clinical practice, its integration holds significant potential to enhance diagnostic accuracy and overall patient management.

Indexed as

artificial intelligenceartificial neural networksdeep convolutional neural networks (DCNN)machine learningnatural language processing (NLP)pulmonary embolism

Identifiers

PMID40218239
PMCPMC11988985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.